Sign in
Not yet recruitingPhase 4

The Effect of Bupivacaine Liposome Preemptive Analgesia on Postoperative Pain and Delirium in Elderly Patients Undergoing Hip Fracture Surgery

Key facts

Who runs it
Nanjing First Hospital, Nanjing Medical University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
Phase
Phase 4
People taking part
40 people, planned
Started
20 Jul 2025
Expected to end
30 Dec 2026
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Tramadol
  • bupivacaine liposome (ultrasound-guided high iliofascial space block)
Record updated
15 July 2025

Who can take part

Age
65 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Patients with hip fractures scheduled for surgical treatment (including femoral neck fractures, intertrochanteric fractures, and fractures more than 5 cm below the lesser trochanter of the femur)
  • Age ≥65 years
  • American Society of Anesthesiologists (ASA) grade I - III
  • The patient or family member signed the informed consent form

Who cannot take part

  • Preoperative delirium or the use of delirium-related medications (such as olanzapine)
  • Have a clear history of mental illness or are taking psychotropic drugs
  • A history of acute cerebrovascular disease (cerebral infarction or cerebral hemorrhage) within 6 months
  • Patients requiring sedation or postoperative coma due to the condition
  • Allergy to amide local anesthetics
  • Severe arrhythmia or liver or kidney dysfunction
  • Compound injuries (such as combined fractures of the head, chest, pelvis, or limbs)

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To explore the effects of bupivacaine liposomes in preemptive analgesia for iliofascial block on postoperative pain and postoperative delirium in elderly patients with hip fractures, to optimize perioperative analgesia strategies, to reduce the incidence of postoperative delirium, and to improve patient prognosis.

The 2 groups in the trial

  • intramuscularlyPlacebo, for comparison

    The elderly patients with hip fractures who were randomly divided into the control group were injected tramadol 100mg intramuscularly.

    Treatment: Tramadol

  • ultrasound-guided high iliofascial space blockTreatment being tested

    The elderly patients with hip fractures who were randomly divided into the experimental group were given ultrasound-guided high iliofascial space block

    Treatment: bupivacaine liposome (ultrasound-guided high iliofascial space block)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effect of Bupivacaine Liposome Preemptive Analgesia on Postoperative Pain and Delirium in Elderly Patients Undergoing Hip Fracture Surgery: A Randomized, Parallel Controlled Prospective Clinical Study
Record updated
15 July 2025